HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION
Clinical trials for HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Women's heart failure: quick drug boost may cut hospital returns
Disease control Not yet recruitingThis study tests whether giving women the full recommended doses of heart failure medications quickly after a hospital stay can reduce the risk of death or readmission within a year. About 360 women from 13 Italian hospitals will be randomly assigned to either intensive medicatio…
Matched conditions: HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION
Phase: PHASE4 • Sponsor: IRCCS Policlinico S. Donato • Aim: Disease control
Last updated May 26, 2026 03:12 UTC
-
New drug NT-88 aims to improve heart function in heart failure patients
Disease control Not yet recruitingThis study tests a new drug called NT-88 in 60 people with chronic heart failure whose hearts pump slightly less blood than normal. The main goal is to check if the drug is safe and if it can improve heart function and symptoms like shortness of breath. Participants will be monit…
Matched conditions: HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION
Phase: NA • Sponsor: Guangzhou Manjing biomedicine technology co., ltd • Aim: Disease control
Last updated May 22, 2026 13:55 UTC